Trial · NCT01667679
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | 20 mg Sumatriptan Nasal Powder | 9 | 219 | |
| other | Nausea | Gastrointestinal disorders | 100 mg Sumatriptan Tablet | 7 | 228 | |
| other | Product taste abnormal | General disorders | 20 mg Sumatriptan Nasal Powder | 57 | 219 | |
| other | Product taste abnormal | General disorders | 100 mg Sumatriptan Tablet | 9 | 228 | |
| other | Ear infection | Infections and infestations | 20 mg Sumatriptan Nasal Powder | 1 | 219 | |
| other | Ear infection | Infections and infestations | 100 mg Sumatriptan Tablet | 3 | 228 | |
| other | Gastroenteritis viral | Infections and infestations | 20 mg Sumatriptan Nasal Powder | 1 | 219 | |
| other | Gastroenteritis viral | Infections and infestations | 100 mg Sumatriptan Tablet | 3 | 228 | |
| other | Sinusitis | Infections and infestations | 20 mg Sumatriptan Nasal Powder | 3 | 219 | |
| other | Sinusitis | Infections and infestations | 100 mg Sumatriptan Tablet | 4 | 228 | |
| other | Upper respiratory tract infection | Infections and infestations | 20 mg Sumatriptan Nasal Powder | 9 | 219 | |
| other | Upper respiratory tract infection | Infections and infestations | 100 mg Sumatriptan Tablet | 8 | 228 | |
| other | Neck pain | Musculoskeletal and connective tissue disorders | 20 mg Sumatriptan Nasal Powder | 1 | 219 | |
| other | Neck pain | Musculoskeletal and connective tissue disorders | 100 mg Sumatriptan Tablet | 3 | 228 | |
| other | Headache | Nervous system disorders | 20 mg Sumatriptan Nasal Powder | 2 | 219 | |
| other | Headache | Nervous system disorders | 100 mg Sumatriptan Tablet | 3 | 228 | |
| other | Nasal discomfort | Respiratory, thoracic and mediastinal disorders | 20 mg Sumatriptan Nasal Powder | 34 | 219 | |
| other | Nasal discomfort | Respiratory, thoracic and mediastinal disorders | 100 mg Sumatriptan Tablet | 3 | 228 | |
| other | Rhinalgia | Respiratory, thoracic and mediastinal disorders | 20 mg Sumatriptan Nasal Powder | 3 | 219 | |
| other | Rhinalgia | Respiratory, thoracic and mediastinal disorders | 100 mg Sumatriptan Tablet | 0 | 228 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01667679/events